Neonatal rhabdomyoma with cardiac dysfunction: favourable response to sirolimus
- 24 March 2022
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 15 (3) , e244915
Abstract
Cardiac rhabdomyoma is the most common cardiac tumour in childhood, with a strong genetic association to tuberous sclerosis complex. Although most of the patients remain asymptomatic, a small proportion present with cardiac complications in the early neonatal period. Timely initiation of treatment can potentially reduce disease morbidity, and mammalian target of rapamycin (M-TOR) inhibitors play an effective role in promoting regression of these tumours. A healthy term newborn was diagnosed with a giant congenital cardiac rhabdomyoma at birth. He developed clinical signs of compromised cardiac function and progressive myocardial ischaemia, with echocardiography showing significant dyskinesia. He was treated with M-TOR inhibitors and clinical response was monitored via serial echocardiography. Remarkable regression of the tumour was visibly demonstrated within 4 months of sirolimus treatment. The infant continues to be reviewed by a multidisciplinary team of physicians and monitored for features of tuberous sclerosis complex.Keywords
This publication has 16 references indexed in Scilit:
- Cardiovascular Manifestations of Tuberous Sclerosis Complex and Summary of the Revised Diagnostic Criteria and Surveillance and Management Recommendations From the International Tuberous Sclerosis Consensus GroupJournal of the American Heart Association, 2014
- Rhabdomyomas and Tuberous sclerosis complex: our experience in 33 casesBMC Cardiovascular Disorders, 2014
- Everolimus treatment of refractory epilepsy in tuberous sclerosis complexAnnals of Neurology, 2013
- Outcome of antenatally diagnosed cardiac rhabdomyoma: case series and a meta‐analysisUltrasound in Obstetrics & Gynecology, 2008
- Clinical and Genotype Studies of Cardiac Tumors in 154 Patients With Tuberous Sclerosis ComplexPediatrics, 2006
- Surgically treated primary cardiac tumors in early infancy and childhoodThe Journal of Thoracic and Cardiovascular Surgery, 2005
- A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytesHuman Molecular Genetics, 2004
- Primary cardiac tumours: when is surgery necessary?European Journal of Cardio-Thoracic Surgery, 2001
- Selected Aspects of Cardiac Tumors in Infancy and ChildhoodPediatric Cardiology, 2000
- Genetic aspects of tuberous sclerosis in the west of Scotland.Journal of Medical Genetics, 1989